Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kai Luo
Institutions:
Guangzhou Medical University Cancer Hospital,
Guangzhou Medical University
Observed institutions:
Guangzhou Medical University Cancer Hospital,
State Key Laboratory of Respiratory Disease,
Guangzhou Medical University
ORCID:
0000-0003-1661-9353
Observed ORCID:
0000-0003-1661-9353
OpenAlex ID:
A5080053615
P21-activated kinase 2-mediated β-catenin signaling promotes cancer stemness and osimertinib resistance in EGFR-mutant non-small-cell lung cancer
2022
·
Yanmei Yi
, Pan Li
, et al.
·
Oncogene
·
31
METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR -Mutant NSCLC Cells
2024
·
Siwen Fan
, Xinwu Lv
, et al.
·
Molecular Cancer Research
·
10
Methylation-modulated PFTK1 regulates gefitinib resistance via Wnt/β-catenin signaling in EGFR mutant non-small-cell lung cancer cells
2024
·
Xiaoting Jia
, Jingjie Tian
, et al.
·
Communications Biology
·
7
PDF
Supplementary Figure 2 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2026
·
Siwen Fan
, Xinwu Lv
, et al.
Supplementary Figure 6 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2026
·
Siwen Fan
, Xinwu Lv
, et al.
Supplementary Figure 1 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2026
·
Siwen Fan
, Xinwu Lv
, et al.
Supplementary Figure 5 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2026
·
Siwen Fan
, Xinwu Lv
, et al.
Supplementary Figure 7 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2026
·
Siwen Fan
, Xinwu Lv
, et al.
Supplementary Figure 3 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2026
·
Siwen Fan
, Xinwu Lv
, et al.
Supplementary Figure 4 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2026
·
Siwen Fan
, Xinwu Lv
, et al.
[Expression of S100P in Lung Adenocarcinoma and Its Clinical Significance].
2026
·
Ziyi Ding
, Donghui Zhang
, et al.
·
PubMed Central
PDF
Identification and validation of serum SLIT1 as a biomarker for predicting anti-PD-1/PD-L1 resistance in non-small cell lung cancer
2026
·
Huisi Qiu
, Cong Peng
, et al.
·
Biological Procedures Online
Supplementary Figure 1 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2024
·
Siwen Fan
, Xinwu Lv
, et al.
Supplementary Figure 7 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2024
·
Siwen Fan
, Xinwu Lv
, et al.
PDF
Data from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2024
·
Siwen Fan
, Xinwu Lv
, et al.
Supplementary Figure 2 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2024
·
Siwen Fan
, Xinwu Lv
, et al.
PDF
Supplementary Figure 6 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2024
·
Siwen Fan
, Xinwu Lv
, et al.
Supplementary Figure 3 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2024
·
Siwen Fan
, Xinwu Lv
, et al.
Supplementary Figure 4 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2024
·
Siwen Fan
, Xinwu Lv
, et al.
PDF
Supplementary Figure 5 from METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells
2024
·
Siwen Fan
, Xinwu Lv
, et al.
PDF
Show more works
View as search
Works count:
20
Citation count:
48
H-index:
3
I10-index:
2
Year
Topic
Type